Longitudinal Magnetization Transfer Imaging in Mild to Severe Alzheimer Disease

References

1. 1.↵
   1. McKhann G,
   2. Drachman D,
   3. Folstein M,
   4. et al

   . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939– 44

   Abstract/FREE Full Text
2. 2.↵
   1. Braak H,
   2. Braak E

   . Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239– 59

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Hyman BT,
   2. Van Hoesen GW,
   3. Damasio AR,
   4. et al

   . Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984; 225: 1168– 70

   Abstract/FREE Full Text
4. 4.↵
   1. Arnold SE,
   2. Hyman BT,
   3. Flory J,
   4. et al

   . The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1991; 1: 103– 16

   Abstract/FREE Full Text
5. 5.↵
   1. Mitew S,
   2. Kirkcaldie MT,
   3. Halliday GM,
   4. et al

   . Focal demyelination in Alzheimer's disease and transgenic mouse models. Acta Neuropathol 2010; 119: 567– 77

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Ihara M,
   2. Polvikoski TM,
   3. Hall R,
   4. et al

   . Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. Acta Neuropathol 2010; 119: 579– 89

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Sluimer JD,
   2. van der Flier WM,
   3. Karas GB,
   4. et al

   . Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients. Radiology 2008; 248: 590– 98

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Henneman WJ,
   2. Sluimer JD,
   3. Barnes J,
   4. et al

   . Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures. Neurology 2009; 72: 999– 1007

   Abstract/FREE Full Text
9. 9.↵
   1. Balaban RS,
   2. Ceckler TL

   . Magnetization transfer contrast in magnetic resonance imaging. Magn Reson Q 1992; 8: 116– 37

   PubMed
10. 10.↵
    1. Schmierer K,
    2. Scaravilli F,
    3. Altmann DR,
    4. et al

    . Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004; 56: 407– 15

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Wolff SD,
    2. Balaban RS

    . Magnetization transfer imaging: practical aspects and clinical applications. Radiology 1994; 192: 593– 99

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Hanyu H,
    2. Asano T,
    3. Iwamoto T,
    4. et al

    . Magnetization transfer measurements of the hippocampus in patients with Alzheimer's disease, vascular dementia, and other types of dementia. AJNR Am J Neuroradiol 2000; 21: 1235– 42

    Abstract/FREE Full Text
13. 13.↵
    1. Hanyu H,
    2. Asano T,
    3. Sakurai H,
    4. et al

    . Magnetization transfer measurements of the hippocampus in the early diagnosis of Alzheimer's disease. J Neurol Sci 2001; 188: 79– 84

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Kabani NJ,
    2. Sled JG,
    3. Shuper A,
    4. et al

    . Regional magnetization transfer ratio changes in mild cognitive impairment. Magn Reson Med 2002; 47: 143– 48

    CrossRefPubMed
15. 15.↵
    1. van der Flier WM,
    2. van den Heuvel DM,
    3. Weverling-Rijnsburger AW,
    4. et al

    . Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann Neurol 2002; 52: 62– 67

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Bozzali M,
    2. Franceschi M,
    3. Falini A,
    4. et al

    . Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI. Neurology 2001; 57: 1135– 37

    Abstract/FREE Full Text
17. 17.↵
    1. Ridha BH,
    2. Symms MR,
    3. Tozer DJ,
    4. et al

    . Magnetization transfer ratio in Alzheimer disease: comparison with volumetric measurements. AJNR Am J Neuroradiol 2007; 28: 965– 70

    Abstract/FREE Full Text
18. 18.↵
    1. Kabani NJ,
    2. Sled JG,
    3. Chertkow H

    . Magnetization transfer ratio in mild cognitive impairment and dementia of Alzheimer's type. Neuroimage 2002; 15: 604– 10

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Van Der Flier WM,
    2. Van Den Heuvel DM,
    3. Weverling-Rijnsburger AW,
    4. et al

    . Cognitive decline in AD and mild cognitive impairment is associated with global brain damage. Neurology 2002; 59: 874– 79

    Abstract/FREE Full Text
20. 20.↵
    1. Schmidt R,
    2. Ropele S,
    3. Pendl B,
    4. et al

    . Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine. J Neurol Neurosurg Psychiatry 2008; 79: 1312– 17

    Abstract/FREE Full Text
21. 21.↵
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV. Washington, DC: Author, 1994
22. 22.↵
    1. Folstein MF,
    2. Folstein SE,
    3. McHugh PR

    . “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189– 98

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Chan D,
    2. Fox NC,
    3. Jenkins R,
    4. et al

    . Rates of global and regional cerebral atrophy in AD and frontotemporal dementia. Neurology 2001; 57: 1756– 63

    Abstract/FREE Full Text
24. 24.↵
    1. Sluimer JD,
    2. Vrenken H,
    3. Blankenstein MA,
    4. et al

    . Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors. Neurology 2008; 70: 1836– 41

    Abstract/FREE Full Text
25. 25.↵
    1. de Jong LW,
    2. van der Hiele K,
    3. Veer IM,
    4. et al

    . Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study. Brain 2008; 131: 3277– 85

    Abstract/FREE Full Text
26. 26.↵
    1. Ginestroni A,
    2. Battaglini M,
    3. Della Nave R,
    4. et al

    . Early structural changes in individuals at risk of familial Alzheimer's disease: a volumetry and magnetization transfer MR imaging study. J Neurol 2009; 256: 925– 32

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Hua J,
    2. Hurst GC

    . Analysis of on- and off-resonance magnetization transfer techniques. J Magn Reson Imaging 1995; 5: 113– 20

    CrossRefPubMed
28. 28.↵
    1. Kirsch SJ,
    2. Jacobs RW,
    3. Butcher LL,
    4. et al

    . Prolongation of magnetic resonance T2 time in hippocampus of human patients marks the presence and severity of Alzheimer's disease. Neurosci Lett 1992; 134: 187– 90

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Wang H,
    2. Yuan H,
    3. Shu L,
    4. et al

    . Prolongation of T(2) relaxation times of hippocampus and amygdala in Alzheimer's disease. Neurosci Lett 2004; 363: 150– 53

    CrossRefPubMed
30. 30.↵
    1. Fazekas F,
    2. Ropele S,
    3. Enzinger C,
    4. et al

    . MTI of white matter hyperintensities. Brain 2005; 128: 2926– 32

    Abstract/FREE Full Text
31. 31.↵
    1. Ropele S,
    2. Enzinger C,
    3. Sollinger M,
    4. et al

    . The impact of sex and vascular risk factors on brain tissue changes with aging: magnetization transfer imaging results of the Austrian stroke prevention study. AJNR Am J Neuroradiol 2010; 31: 1297– 301

    Abstract/FREE Full Text
32. 32.↵
    1. Ropele S,
    2. Filippi M,
    3. Valsasina P,
    4. et al

    . Assessment and correction of B1-induced errors in magnetization transfer ratio measurements. Magn Reson Med 2005; 53: 134– 40

    CrossRefPubMedWeb of Science
33. 33.↵
    1. van Es AC,
    2. van der Flier WM,
    3. Admiraal-Behloul F,
    4. et al

    . Lobar distribution of changes in gray matter and white matter in memory clinic patients: detected using magnetization transfer imaging. AJNR Am J Neuroradiol 2007; 28: 1938– 42

    Abstract/FREE Full Text
34. 34.↵
    1. Ridha BH,
    2. Tozer DJ,
    3. Symms MR,
    4. et al

    . Quantitative magnetization transfer imaging in Alzheimer disease. Radiology 2007; 244: 832– 37

    CrossRefPubMed